Teza Capital Management LLC Buys 1,777 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Teza Capital Management LLC lifted its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 6.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,884 shares of the company’s stock after purchasing an additional 1,777 shares during the quarter. Teza Capital Management LLC’s holdings in Privia Health Group were worth $604,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Quadrant Capital Group LLC raised its stake in Privia Health Group by 11.8% during the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock worth $95,000 after buying an additional 511 shares during the period. Park Avenue Securities LLC raised its position in shares of Privia Health Group by 3.8% during the fourth quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock worth $287,000 after purchasing an additional 532 shares during the period. PNC Financial Services Group Inc. raised its position in shares of Privia Health Group by 8.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company’s stock worth $140,000 after purchasing an additional 533 shares during the period. First Horizon Advisors Inc. lifted its holdings in shares of Privia Health Group by 53.8% in the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after purchasing an additional 632 shares in the last quarter. Finally, Summit Investment Advisors Inc. increased its stake in Privia Health Group by 6.8% during the 4th quarter. Summit Investment Advisors Inc. now owns 10,673 shares of the company’s stock valued at $209,000 after purchasing an additional 678 shares in the last quarter. Institutional investors own 94.48% of the company’s stock.

Insider Buying and Selling

In other Privia Health Group news, CFO David Mountcastle sold 5,630 shares of the business’s stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total value of $125,999.40. Following the completion of the transaction, the chief financial officer now owns 179,676 shares of the company’s stock, valued at $4,021,148.88. The trade was a 3.04% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Matthew Shawn Morris sold 10,309 shares of the firm’s stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $23.33, for a total value of $240,508.97. Following the sale, the director now owns 59,792 shares in the company, valued at $1,394,947.36. The trade was a 14.71% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 51,579 shares of company stock valued at $1,226,367. Company insiders own 10.70% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently weighed in on PRVA shares. Barclays raised their price target on shares of Privia Health Group from $21.00 to $23.00 and gave the company an “equal weight” rating in a research report on Thursday, April 10th. Robert W. Baird increased their price target on Privia Health Group from $24.00 to $26.00 and gave the company an “outperform” rating in a research report on Tuesday, April 15th. Needham & Company LLC reaffirmed a “buy” rating and set a $30.00 price objective on shares of Privia Health Group in a report on Thursday, April 10th. Truist Financial increased their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the company a “buy” rating in a report on Thursday, April 10th. Finally, Canaccord Genuity Group boosted their price target on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a report on Friday, February 28th. One research analyst has rated the stock with a hold rating, eleven have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $27.38.

Privia Health Group Price Performance

NASDAQ:PRVA opened at $25.00 on Tuesday. The company has a market capitalization of $3.05 billion, a P/E ratio of 250.03, a P/E/G ratio of 3.47 and a beta of 0.87. The business has a fifty day simple moving average of $23.38 and a two-hundred day simple moving average of $22.61. Privia Health Group, Inc. has a 1 year low of $15.92 and a 1 year high of $26.09.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.